Connection

Aryan Namboodiri to Half-Life

Back to Details
This is a "connection" page, showing publications Aryan Namboodiri has written about Half-Life.
Aryan Namboodiri
Connection Strength
0.038
Half-Life
  1. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS Med. 2018 01; 15(1):e1002493.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.